←Back to Expert Scholars
Translational Medicine / 转化医学MET Exon 14 Skipping Alterations
Egbert Smit
MD, PhD
🏢Leiden University Medical Center🌐Netherlands
Professor of Thoracic Oncology
72
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Egbert Smit is a leading European thoracic oncologist who has contributed to MET exon 14 skipping clinical trials and molecular diagnostics. His research has defined treatment sequencing strategies for MET-altered NSCLC. He is a key contributor to ESMO guidelines for molecular testing in lung cancer.
Share:
🧪Research Fields 研究领域
MET exon 14 skipping
NSCLC treatment
Molecular diagnostics
European clinical trials
Thoracic oncology
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Egbert Smit 的研究动态
Follow Egbert Smit's research updates
留下邮箱，当我们发布与 Egbert Smit（Leiden University Medical Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment